SCHOTT HERBERT has a total of 15 patent applications. Its first patent ever was published in 1992. It filed its patents most often in EPO (European Patent Office), Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are PHARMASSET LTD, PHARMASSET INC and GENSIA SICOR.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 1 | |
#5 | Germany | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Heterocyclic compounds | |
#5 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Schott Herbert | 13 |
#2 | Ludwig Peter Stephan | 5 |
#3 | Guerin Frederique | 3 |
#4 | Schwendener Albert Reto | 3 |
#5 | Kluge Michael | 2 |
#6 | Ludwig Peter | 1 |
#7 | Schott Herbert Prof Dr | 1 |
Publication | Filing date | Title |
---|---|---|
US2013237494A1 | Bone-targeting bisphosphonate duplex drugs | |
DE19855963A1 | Amphiphilic glyceryl nucleotides, process for their preparation and their use | |
CA2129986A1 | Amphiphile nucleosidphosphatanaloga |